International Journal of Celiac Disease
ISSN (Print): 2334-3427 ISSN (Online): 2334-3486 Website: Editor-in-chief: Samasca Gabriel
Open Access
Journal Browser
International Journal of Celiac Disease. 2017, 5(3), 95-96
DOI: 10.12691/ijcd-5-3-6
Open AccessEditorial

Deamidated Gliadin Peptide Antibodies; is the Time to Use as a Routine Test for Celiac Disease

Mohammad Rostami Nejad1,

1Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Pub. Date: August 08, 2017

Cite this paper:
Mohammad Rostami Nejad. Deamidated Gliadin Peptide Antibodies; is the Time to Use as a Routine Test for Celiac Disease. International Journal of Celiac Disease. 2017; 5(3):95-96. doi: 10.12691/ijcd-5-3-6


Antibodies to deamidated gliadin peptides (DGP-AGA) have newly been presented into the extensive variety of serologic examinations for celiac disease (CD). In compare with the modern AGA, DGP-AGA indicated a higher sensitivity and specificity for CD and simply identified by ELISA kits. Nevertheless, even though the very favorable outcomes, DGP-AGA are not yet regularly used in the serologic checkup for CD. An antibody approach could initiate development in the diagnostic precision of serology for CD screening.

deamidated gliadin peptides celiac disease serologic checkup

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  Rostami Nejad, M. Celiac disease and non-celiac gluten sensitivity; evidences and differences. International Journal of Celiac Disease 2013;1(1): 6-7.
[2]  Zali MR, Rostami Nejad M, Rostami K, Alavian SM. Liver complications in celiac disease. Hepat Mon. 2011;11(5):333-41.
[3]  Gatselis NK, Zachou K, Norman GL, Tzellas G, Speletas M, Gabeta S, et al. IgA antibodies against deamidated gliadin peptides in patients with chronic liver diseases. Clinica chimica acta; international journal of clinical chemistry. 2012.
[4]  Naiyer AJ, Hernandez L, Ciaccio EJ, Papadakis K, Manavalan JS, Bhagat G, et al. Comparison of commercially available serologic kits for the detection of celiac disease. J Clin Gastroenterol. 2009;43(3):225-32.
[5]  Volta U, Granito A, Parisi C, Fabbri A, Fiorini E, Piscaglia M, et al. Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis. J Clin Gastroenterol. 2010;44(3):186-90.
[6]  Rashtak S, Ettore MW, Homburger HA, Murray JA. Combination testing for antibodies in the diagnosis of coeliac disease: comparison of multiplex immunoassay and ELISA methods. Aliment Pharmacol Ther. 2008;28(6):805-13.
[7]  Volta U, Fabbri A, Parisi C, Piscaglia M, Caio G, Tovoli F, et al. Old and new serological tests for celiac disease screening. Expert Rev Gastroenterol Hepatol. 2010;4(1):31-5.
[8]  Samaşca G, Iancu M, Butnariu A, Andreica M, Dejica D. New Para-Clinical Investigations in the Celiac Disease. Romanian Rev Lab Med 2010;18(2):43-51.
[9]  Marti CO, Fellay B, Bürgin-Wolff A, Magnin J-L, Baehler P. Evaluation of a DGP Point-of-care Test for Celiac Disease in a Pediatric Population. International Journal of Celiac Disease. 2015;3(1):7-11.
[10]  Hong YY. Deaminated Gliadin Peptide Antibody in the Diagnosis of Celiac Disease. International Journal of Celiac Disease. 2015:3(2):56-57.